Align Technology (XTER:AFW) Cyclically Adjusted Revenue per Share: €37.58 (As of Mar. 2026)


XTER:AFW Align Technology Inc XTER:AFW
89 GF Score
Price €161.55
GF Value €216.07
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Align Technology Cyclically Adjusted Revenue per Share?

Align Technology XTER:AFW 89 Cyclically Adjusted Revenue per Share is €37.58 as of Mar. 2026. GuruFocus rates XTER:AFW with a GF Score™ of 89/100 and a GF Value™ of €216.07 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Align Technology's adjusted revenue per share for the three months ended in Mar. 2026 was €12.563. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €37.58 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Align Technology's average Cyclically Adjusted Revenue Growth Rate was 14.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 15.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 20.30% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 22.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Align Technology was 25.70% per year. The lowest was 12.40% per year. And the median was 19.20% per year.

As of today (2026-07-13), Align Technology's current stock price is €161.55. Align Technology's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €37.58. Align Technology's Cyclically Adjusted PS Ratio of today is 4.30.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Align Technology was 38.66. The lowest was 3.03. And the median was 13.93.


Align Technology  (XTER:AFW) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Align Technology's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=161.55/37.58
=4.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Align Technology was 38.66. The lowest was 3.03. And the median was 13.93.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Align Technology Cyclically Adjusted Revenue per Share Related Terms


Align Technology Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Align Technology's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Align Technology Cyclically Adjusted Revenue per Share Chart

Align Technology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.43 25.57 36.99 56.21 36.63

Align Technology Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 76.74 66.68 104.07 36.63 37.58

XTER:AFW vs SOLV, COO, BAX: Cyclically Adjusted Revenue per Share Comparison

For the Medical Instruments & Supplies subindustry, Align Technology's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Align Technology Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Align Technology's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Align Technology's Cyclically Adjusted PS Ratio falls into.


XTER:AFW
89GF Score
Align Technology Inc XTER:AFW
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Align Technology Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Align Technology's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=12.563/330.2130*330.2130
=12.563

Current CPI (Mar. 2026) = 330.2130.

Align Technology Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 2.949 241.018 4.040
201609 3.047 241.428 4.168
201612 3.416 241.432 4.672
201703 3.559 243.801 4.820
201706 3.887 244.955 5.240
201709 3.952 246.819 5.287
201712 4.339 246.524 5.812
201803 4.341 249.554 5.744
201806 5.151 251.989 6.750
201809 5.322 252.439 6.962
201812 5.808 251.233 7.634
201903 6.021 254.202 7.821
201906 6.597 256.143 8.505
201909 6.908 256.759 8.884
201912 7.383 256.974 9.487
202003 6.309 258.115 8.071
202006 3.972 257.797 5.088
202009 7.873 260.280 9.988
202012 8.608 260.474 10.913
202103 9.419 264.877 11.742
202106 10.535 271.696 12.804
202109 10.860 274.310 13.073
202112 11.457 278.802 13.570
202203 11.159 287.504 12.817
202206 11.677 296.311 13.013
202209 11.494 296.808 12.788
202212 10.949 296.797 12.182
202303 11.424 301.836 12.498
202306 12.062 305.109 13.054
202309 11.711 307.789 12.564
202312 11.586 306.746 12.472
202403 12.183 312.332 12.880
202406 12.702 314.175 13.350
202409 11.786 315.301 12.343
202412 12.753 315.605 13.343
202503 12.305 319.799 12.706
202506 12.092 322.561 12.379
202509 11.714 324.800 11.909
202512 12.475 324.054 12.712
202603 12.563 330.213 12.563

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €37.58 mean?
Align Technology (XTER:AFW) has a Cyclically Adjusted Revenue per Share of €37.58 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Align Technology and its competitors.
Is Align Technology's Cyclically Adjusted Revenue per Share too high?
Align Technology's current Cyclically Adjusted Revenue per Share is €37.58. Overall, Align Technology has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Align Technology's Cyclically Adjusted Revenue per Share compare to SOLV and COO?
Align Technology's Cyclically Adjusted Revenue per Share of €37.58 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Align Technology and its competitors. Align Technology's current Cyclically Adjusted Revenue per Share is €37.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Align Technology stock overvalued right now?
Based on GuruFocus' analysis, Align Technology (XTER:AFW) is currently considered Modestly Undervalued. The stock's GF Value™ is €216.07, compared to a current price of €161.55 — trading 25.2% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €37.58. Align Technology's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Align Technology (XTER:AFW), the current Cyclically Adjusted Revenue per Share is €37.58 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Align Technology (XTER:AFW) Overvalued in 2026?

Based on GuruFocus' analysis, Align Technology stock appears to be undervalued. The current stock price of €161.55 is trading 25.2% below its estimated GF Value™ of €216.07. GuruFocus considers Align Technology to be Modestly Undervalued.

Key valuation signals for XTER:AFW:

  • Cyclically Adjusted Revenue per Share: €37.58
  • GF Value™: €216.07 vs. price of €161.55 (25.2% below fair value)
  • GF Score™: 89/100 with 3 warning signs

No single metric tells the full story. See the XTER:AFW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Align Technology Business Description

Address 410 North Scottsdale Road, Suite 1300, Tempe, AZ, USA, 85288
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
89GF Score

Get the complete analysis for XTER:AFW

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€161.55
Price
€216.07
GF Value